Objective: To systematically evaluate the construction status of pharmacy intravenous admixture services (PIVAS)

so as to provide reference for the construction and development direction of PIVAS in China. Methods: PubMed

EMBase

the Cochrane Library

CBM

CNKI

VIP

Wanfang database were retrieved to collect the literature of current status of PIVAS construction in China. The retrieval time was from the establishment of the database to Jan. 2019. Indicators such as site

equipment

staffing

opening of wards and beds

effectiveness and problems were collected

and the results were presented by descriptive analysis. Results: A total of twenty-four studies were included. The research types were 14 experience sharing studies (58%) and 10 reviews (42%). There were great differences in the area

equipment

staffing

opening of wards and beds

and the average daily infusion volume of PIVAS in various provinces and cities in China. The construction of PIVAS can ensure the safety of intravenous drug use

save costs and improve the quality of nursing. However

there was no unified management specification

and investment in the early stage was relatively high. Conclusion: There are differences in the construction status of PIVAS in hospitals in China

some achievements have generally been made

yet there are still some problems. It is suggested to develop PIVAS through referring to the construction standards in China and combining the actual conditions of each hospital.